Simeprevir plus sofosbuvir (12 and 8 weeks) in hepatitis C virus genotype 1-infected patients without cirrhosis: OPTIMIST-1, a phase 3, randomized study - Kwo, P; Gitlin, N; Nahass, R (Hepatology, 2016)
, et al.